Taq DNA Polymerase Variants with Increased Reverse Transcriptase Activity
AssigneeAbClonal Science, Inc.
InventorsZhenyu Zhu, Dapeng Sun, Aine Quimby, Nicholas J. DeBerardinis, Krista Ferrari
Life of this patent
Estimating the term…
Loading patent…
AssigneeAbClonal Science, Inc.
InventorsZhenyu Zhu, Dapeng Sun, Aine Quimby, Nicholas J. DeBerardinis, Krista Ferrari
Estimating the term…
Taq DNA polymerase mutants exhibiting reverse transcriptase activity compared to wild type polymerase were engineered, characterized, and selected via polymerase chain reactions visualized via electrophoresis on agarose gels. Initial screening was followed up with probe-based qualitative, real-time PCR (qPCR) with a typical reverse transcription cycling protocol to detect specified ribonucleic acid (RNA) target sequences. The engineered variants can render robust cDNA from RNA target substrates and amplify that cDNA under standard reaction conditions without the assistance of added reverse transcriptase enzymes.
A mutant Taq polymerase comprising:
A reverse transcription PCR process comprising:
A reverse transcription qPCR process comprising:
Dependencies are inferred from the claim text.